<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00259207</url>
  </required_header>
  <id_info>
    <org_study_id>P040413</org_study_id>
    <secondary_id>AOR04068</secondary_id>
    <nct_id>NCT00259207</nct_id>
  </id_info>
  <brief_title>Pulmonary Valve Replacement in Large Right Ventricular Outflow Tract</brief_title>
  <official_title>Pulmonary Valve Replacement : Study of Comparison Between a Standard Surgical Approach With Extracorporeal Circulation and an Off-pump Hybrid Strategy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - H么pitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>H么pital Necker-Enfants Malades</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>European Georges Pompidou Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - H么pitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare 2 techniques of pulmonary valve replacement in&#xD;
      patients with a large right ventricular outflow tract: a standard surgical treatment using&#xD;
      cardiopulmonary bypass versus a medico-surgical hybrid strategy without extracorporeal&#xD;
      circulation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulmonary regurgitation is a common complication late after complete correction of a&#xD;
      tetralogy of Fallot. It progressively leads to a right ventricular dilatation that has been&#xD;
      strongly associated with ventricular arrhythmia, sudden death and right ventricular&#xD;
      insufficiency. Pulmonary valve replacement reduces the rate of complications but the precise&#xD;
      timing for this procedure remains unknown. Moreover, pulmonary valve replacement, even before&#xD;
      the occurrence of symptoms, doesn't allow for a total recovery in all patients. Reasons are&#xD;
      not known, but cardiopulmonary bypass as well as late referral to surgery have been&#xD;
      incriminated to explain the persistence of right ventricular dysfunction after surgical&#xD;
      valvular. Therefore, a strategy avoiding cardiopulmonary bypass could potentially preserve&#xD;
      the right ventricular function and in the meantime reduce the hospitalisation length and&#xD;
      morbid-mortality. For the last six years, we and others have developed a technique of&#xD;
      percutaneous pulmonary valve implantation. Encouraging results were reported in the treatment&#xD;
      of failing right ventricular to pulmonary artery conduit, but presents indications are&#xD;
      limited and the innovative technique could not be offered to most of patients requiring&#xD;
      pulmonary valve replacement. In particular, to date, conventional surgery is the only&#xD;
      approach for patients with large pulmonary trunk over 22 mm in diameter. We had the idea of&#xD;
      collaborating with the surgeons to try to improve the outcome of valvular in these patients.&#xD;
      We would like to investigate a hybrid strategy in those patients with large right ventricular&#xD;
      outflow tract inaccessible to solely transcatheter technique. The studied technique will&#xD;
      associate a surgical pulmonary artery banding without cardiopulmonary bypass immediately&#xD;
      followed by a transventricular or a transvenous pulmonary valve insertion using a&#xD;
      conventional valved stent. The purpose of this randomized study is to evaluate benefits and&#xD;
      risks of the medico-surgical hybrid strategy, and to compare both strategies hybrid approach&#xD;
      and conventional surgery with extracorporeal circulation in term of right ventricular&#xD;
      function recovery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Right ventricular function</measure>
    <time_frame>during the study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity and mortality</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Pulmonary Valve Insufficiency</condition>
  <arm_group>
    <arm_group_label>classic surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>classic surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>medical surgery hybride</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>medical surgery hybride</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pulmonary valve insertion</intervention_name>
    <description>Pulmonary valve insertion</description>
    <arm_group_label>classic surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>medical surgery hybride</intervention_name>
    <description>medical surgery hybride</description>
    <arm_group_label>medical surgery hybride</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient with surgical indication of pulmonary valve replacement for significant&#xD;
             pulmonary regurgitation&#xD;
&#xD;
          2. Pulmonary trunk diameter &gt; 22mm&#xD;
&#xD;
          3. Age &gt; 5 years old or weight &gt; 20kg&#xD;
&#xD;
          4. Acceptance of protocol&#xD;
&#xD;
          5. Social regimen security&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. No indication of pulmonary valve replacement&#xD;
&#xD;
          2. Age &lt; 5 years old or weight &lt; 20kg&#xD;
&#xD;
          3. Extra-cardiac disease with a vital prognosis under 6 months&#xD;
&#xD;
          4. Heparin and contrast allergy&#xD;
&#xD;
          5. Clinical or biological signs of infection&#xD;
&#xD;
          6. Pregnancy&#xD;
&#xD;
          7. Patients in emergency state&#xD;
&#xD;
          8. Patients included in an another research protocol during the last months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Younes BOUDJEMLINE, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - H么pitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NECKER HOSPITAL for Sick Children, 149 R. de SEVRES</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Boudjemline Y, Schievano S, Bonnet C, Coats L, Agnoletti G, Khambadkone S, Bonnet D, Deanfield J, Sidi D, Bonhoeffer P. Off-pump replacement of the pulmonary valve in large right ventricular outflow tracts: a hybrid approach. J Thorac Cardiovasc Surg. 2005 Apr;129(4):831-7.</citation>
    <PMID>15821651</PMID>
  </reference>
  <verification_date>March 2007</verification_date>
  <study_first_submitted>November 28, 2005</study_first_submitted>
  <study_first_submitted_qc>November 28, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2005</study_first_posted>
  <last_update_submitted>September 29, 2009</last_update_submitted>
  <last_update_submitted_qc>September 29, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2009</last_update_posted>
  <responsible_party>
    <name_title>Cecile Jourdain</name_title>
    <organization>Department Clinical Research of Developpement</organization>
  </responsible_party>
  <keyword>Pulmonary valve regurgitation</keyword>
  <keyword>Valve replacement</keyword>
  <keyword>Hybrid procedure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

